Even the largest clinical trials won’t capture all possible bad reactions to a drug – we need pharmacovigilance
Derek Lowe lays out how the trials work, and why they get paused and restarted
How long will it take to develop a coronavirus vaccine and why is it so hard?
The fastest route to treatments may be to repurpose existing drugs – if they work
Brian Clegg on the popular over-the-counter painkiller, developed by a high-street pharmacy chain
What does spotting new risks in approved medicines say about how effective regulators are?
European medicines regulator names and shames Swiss giant for not disclosing 80,000 instances of potential adverse drug reactions
© Royal Society of Chemistry Registered charity number: 207890
Site powered by Webvision Cloud